Exposure to High-Fat Style Diet Induced Renal and Liver Structural Changes, Lipid Accumulation and Inflammation in Intact and Ovariectomized Female Rats

References

• Jiang S-Z, Lu W, Zong X-F, Ruan H-Y, Liu Y. Obesity and hypertension. Exp Ther Med. 2016;12(4):2395–2399. doi:10.3892/etm.2016.3667
   PubMed Web of Science ®Google Scholar
• Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–863. doi:10.5114/aoms.2016.58928
   PubMed Web of Science ®Google Scholar
• Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 1983;72(3):1150–1162. doi:10.1172/JCI111040
   PubMed Web of Science ®Google Scholar
• Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29(1):415–445. doi:10.1146/annurev-immunol-031210-101322
   PubMedGoogle Scholar
• Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367–377. doi:10.1038/nrm2391
   PubMed Web of Science ®Google Scholar
• Musaad S, Haynes EN. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev. 2007;29(1):98–114. doi:10.1093/epirev/mxm005
   PubMedGoogle Scholar
• Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002;10(Suppl 2):97s–104s. doi:10.1038/oby.2002.202
   PubMedGoogle Scholar
• Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73(8):947–955. doi:10.1038/sj.ki.5002796
   PubMed Web of Science ®Google Scholar
• Börgeson E, Sharma K. Obesity, immunomodulation and chronic kidney disease. Curr Opin Pharmacol. 2013;13(4):618–624. doi:10.1016/j.coph.2013.05.011
   PubMed Web of Science ®Google Scholar
• Saja MF, Cook HT, Ruseva MM, et al. A triglyceride-rich lipoprotein environment exacerbates renal injury in the accelerated nephrotoxic nephritis model. Clin Exp Immunol. 2018;192(3):337–347. doi:10.1111/cei.13111
   PubMed Web of Science ®Google Scholar
• Muller CR, Leite APO, Yokota R, et al. Post-weaning exposure to high-fat diet induces kidney lipid accumulation and function impairment in adult rats. Front Nutr. 2019;6:60. doi:10.3389/fnut.2019.00060
   PubMed Web of Science ®Google Scholar
• Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65(8):1017–1025. doi:10.1016/j.metabol.2016.01.012
   PubMed Web of Science ®Google Scholar
• Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343–1351. doi:10.1172/JCI23621
   PubMed Web of Science ®Google Scholar
• Adams JM, Pei H, Sandoval DA, et al. Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons. Diabetes. 2018;67(8):1538–1548. doi:10.2337/db17-1385
   PubMed Web of Science ®Google Scholar
• Poniachik J, Csendes A, Díaz JC, et al. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine. 2006;33(5):252–257. doi:10.1016/j.cyto.2006.02.006
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103(6):1372–1379. doi:10.1111/j.1572-0241.2007.01774.x
   PubMed Web of Science ®Google Scholar
• Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav. 2009;97(2):199–204.
   PubMed Web of Science ®Google Scholar
• Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci. 2003;24(6):276–283. doi:10.1016/S0165-6147(03)00132-9
   PubMed Web of Science ®Google Scholar
• van Harmelen V, Dicker A, Rydén M, et al. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes. 2002;51(7):2029–2036. doi:10.2337/diabetes.51.7.2029
   PubMed Web of Science ®Google Scholar
• Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care. 2003;26(3):650–655. doi:10.2337/diacare.26.3.650
   PubMed Web of Science ®Google Scholar
• Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003;88(6):2534–2540. doi:10.1210/jc.2002-021267
   PubMed Web of Science ®Google Scholar
• Rattarasarn C, Leelawattana R, Soonthornpun S, et al. Regional abdominal fat distribution in lean and obese Thai type 2 diabetic women: relationships with insulin sensitivity and cardiovascular risk factors. Metabolism. 2003;52(11):1444–1447. doi:10.1016/S0026-0495(03)00257-9
   PubMed Web of Science ®Google Scholar
• Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care. 2003;26(8):2341–2344. doi:10.2337/diacare.26.8.2341
   PubMed Web of Science ®Google Scholar
• Nieves DJ, Cnop M, Retzlaff B, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52(1):172–179. doi:10.2337/diabetes.52.1.172
   PubMed Web of Science ®Google Scholar
• Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab. 2000;26(3):178–182.
   PubMed Web of Science ®Google Scholar
• You T, Nicklas BJ, Ding J. The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. J Gerontol a Biol Sci Med Sci. 2008;63(4):414–419. doi:10.1093/gerona/63.4.414
   PubMed Web of Science ®Google Scholar
• Jeong YH, Hur HJ, Jeon EJ, et al. Honokiol improves liver steatosis in ovariectomized mice. Molecules. 2018;23(1):194. doi:10.3390/molecules23010194
   PubMed Web of Science ®Google Scholar
• Zhang X, Jia Y, Jackson EK, Tofovic SP. 2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats. J Cardiovasc Pharmacol. 2007;49(1):56–63. doi:10.1097/FJC.0b013e31802cb88e
   PubMed Web of Science ®Google Scholar
• Amaral LS, Silva JA, Trindade TM, et al. Renal changes in the early stages of diet-induced obesity in ovariectomized rats. Physiol Res. 2014;63(6):723–732. doi:10.33549/physiolres.932619
   PubMed Web of Science ®Google Scholar
• Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006;48(4):677–685. doi:10.1016/j.jacc.2006.03.052
   PubMed Web of Science ®Google Scholar
• Novella S, Pérez-Cremades D, Mompeón A, Hermenegildo C. Mechanisms underlying the influence of oestrogen on cardiovascular physiology in women. J Physiol. 2019;597(19):4873–4886. doi:10.1113/JP278063
   PubMed Web of Science ®Google Scholar
• Störk S, von Schacky C, Angerer P. The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis. 2002;165(2):301–307. doi:10.1016/S0021-9150(02)00242-3
   PubMed Web of Science ®Google Scholar
• Kip KE, Marroquin OC, Shaw LJ, et al. Global inflammation predicts cardiovascular risk in women: a report from the women’s ischemia syndrome evaluation (WISE) study. Am Heart J. 2005;150(5):900–906. doi:10.1016/j.ahj.2005.02.002
   PubMed Web of Science ®Google Scholar
• Cutolo M, Capellino S, Sulli A, et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci. 2006;1089(1):538–547. doi:10.1196/annals.1386.043
   PubMedGoogle Scholar
• Khajuria DK, Razdan R, Mahapatra DR. Description of a new method of ovariectomy in female rats. Rev Bras Reumatol. 2012;52(3):462–470.
   PubMed Web of Science ®Google Scholar
• Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology. 2009;150(5):2109–2117. doi:10.1210/en.2008-0971
   PubMed Web of Science ®Google Scholar
• Sucedaram Y, Johns EJ, Husain R, et al. Comparison of high-fat style diet-induced dysregulation of baroreflex control of renal sympathetic nerve activity in intact and ovariectomized female rats: renal sympathetic nerve activity in high-fat style diet fed intact and ovariectomized female rats. Exp Biol Med (Maywood). 2020;245(9):761–776. doi:10.1177/1535370220915673
   PubMed Web of Science ®Google Scholar
• Al-Hussaini H, Kilarkaje N. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys. Toxicol Appl Pharmacol. 2018;339:97–109. doi:10.1016/j.taap.2017.11.025
   PubMed Web of Science ®Google Scholar
• Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension. 2000;35(4):1009–1015. doi:10.1161/01.HYP.35.4.1009
   PubMed Web of Science ®Google Scholar
• Donath MY, Dalmas É, Sauter NS, Böni-Schnetzler M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 2013;17(6):860–872. doi:10.1016/j.cmet.2013.05.001
   PubMed Web of Science ®Google Scholar
• Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107.
   PubMed Web of Science ®Google Scholar
• McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity. 2014;41(1):36–48. doi:10.1016/j.immuni.2014.05.010
   PubMed Web of Science ®Google Scholar
• Masoodi M, Kuda O, Rossmeisl M, Flachs P, Kopecky J. Lipid signaling in adipose tissue: connecting inflammation & metabolism. Biochim Biophys Acta. 2015;1851(4):503–518.
   PubMed Web of Science ®Google Scholar
• Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol. 2013;19(6):802–812. doi:10.3748/wjg.v19.i6.802
   PubMed Web of Science ®Google Scholar
• Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int. 2009;76(2):145–148. doi:10.1038/ki.2009.137
   PubMed Web of Science ®Google Scholar
• Kaaja RJ. Metabolic syndrome and the menopause. Menopause Int. 2008;14(1):21–25. doi:10.1258/MI.2007.007032
   PubMedGoogle Scholar
• Hong J, Stubbins RE, Smith RR, Harvey AE, Núñez NP. Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr J. 2009;8(1):11. doi:10.1186/1475-2891-8-11
   PubMedGoogle Scholar
• Louet JF, LeMay C, Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep. 2004;6(3):180–185. doi:10.1007/s11883-004-0030-9
   PubMedGoogle Scholar
• Ludgero-Correia A Jr, Aguila MB, Mandarim-de-lacerda CA, Faria TS. Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice. Nutrition. 2012;28(3):316–323. doi:10.1016/j.nut.2011.07.014
   PubMed Web of Science ®Google Scholar
• Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1–4. doi:10.1172/JCI92035
   PubMed Web of Science ®Google Scholar
• Vieira Potter VJ, Strissel KJ, Xie C, et al. Adipose tissue inflammation and reduced insulin sensitivity in ovariectomized mice occurs in the absence of increased adiposity. Endocrinology. 2012;153(9):4266–4277. doi:10.1210/en.2011-2006
   PubMed Web of Science ®Google Scholar
• Godsland IF. Oestrogens and insulin secretion. Diabetologia. 2005;48(11):2213–2220. doi:10.1007/s00125-005-1930-0
   PubMed Web of Science ®Google Scholar
• Dorresteijn JA, Visseren FL, Spiering W. Mechanisms linking obesity to hypertension. Obes Rev. 2012;13(1):17–26. doi:10.1111/j.1467-789X.2011.00914.x
   PubMed Web of Science ®Google Scholar
• Cheung BMY, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep. 2012;14(2):160–166. doi:10.1007/s11883-012-0227-2
   PubMed Web of Science ®Google Scholar
• Maric-Bilkan C, Gilbert EL, Ryan MJ. Impact of ovarian function on cardiovascular health in women: focus on hypertension. Int J Womens Health. 2014;6:131–139. doi:10.2147/IJWH.S38084
   PubMedGoogle Scholar
• Declèves AE, Sharma K. Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Curr Opin Nephrol Hypertens. 2015;24(1):28–36. doi:10.1097/MNH.0000000000000087
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73(1):19–33. doi:10.1038/sj.ki.5002586
   PubMed Web of Science ®Google Scholar
• McPherson KC, Shields CA, Poudel B, et al. Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity. Am J Physiol Renal Physiol. 2019;316(2):F316–f327. doi:10.1152/ajprenal.00162.2018
   PubMed Web of Science ®Google Scholar
• Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol. 2004;286(4):F606–616. doi:10.1152/ajprenal.00269.2003
   PubMed Web of Science ®Google Scholar
• Khan SA, Sattar MZA, Abdullah NA, et al. Improvement in baroreflex control of renal sympathetic nerve activity in obese Sprague Dawley rats following immunosuppression. Acta Physiol (Oxf). 2017;221(4):250–265. doi:10.1111/apha.12891
   PubMed Web of Science ®Google Scholar
• Altunkaynak ME, Ozbek E, Altunkaynak BZ, Can I, Unal D, Unal B. The effects of high-fat diet on the renal structure and morphometric parametric of kidneys in rats. J Anat. 2008;212(6):845–852. doi:10.1111/j.1469-7580.2008.00902.x
   PubMed Web of Science ®Google Scholar
• Handa K, Kreiger N. Diet patterns and the risk of renal cell carcinoma. Public Health Nutr. 2002;5(6):757–767. doi:10.1079/PHN2002347
   PubMed Web of Science ®Google Scholar
• Jiang T, Wang Z, Proctor G, et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem. 2005;280(37):32317–32325. doi:10.1074/jbc.M500801200
   PubMed Web of Science ®Google Scholar
• Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32(5):593–604. doi:10.1016/j.immuni.2010.05.007
   PubMed Web of Science ®Google Scholar
• Mankhey RW, Bhatti F, Maric C. 17Beta-estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol. 2005;288(2):F399–405. doi:10.1152/ajprenal.00195.2004
   PubMed Web of Science ®Google Scholar
• Maric C, Sandberg K, Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. J Am Soc Nephrol. 2004;15(6):1546–1556. doi:10.1097/01.ASN.0000128219.65330.EA
   PubMed Web of Science ®Google Scholar
• Elliot SJ, Karl M, Berho M, et al. Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. Am J Pathol. 2003;162(5):1441–1448. doi:10.1016/S0002-9440(10)64277-0
   PubMed Web of Science ®Google Scholar
• Antus B, Hamar P, Kokeny G, et al. Estradiol is nephroprotective in the rat remnant kidney. Nephrol Dial Transplant. 2003;18(1):54–61. doi:10.1093/ndt/18.1.54
   PubMed Web of Science ®Google Scholar
• Sakemi T, Tomiyoshi Y, Miyazono M, Ikeda Y. Estrogen replacement therapy with its physiological dose does not eliminate the aggravating effect of ovariectomy on glomerular injury in hypercholesterolemic female Imai rats. Nephron. 1998;80(3):324–330. doi:10.1159/000045193
   PubMed Web of Science ®Google Scholar
• Catanuto P, Doublier S, Lupia E, et al. 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int. 2009;75(11):1194–1201. doi:10.1038/ki.2009.69
   PubMed Web of Science ®Google Scholar
• Monteiro R, Teixeira D, Calhau C. Estrogen signaling in metabolic inflammation. Mediators Inflamm. 2014;2014:615917. doi:10.1155/2014/615917
   PubMed Web of Science ®Google Scholar
• Sanz AB, Sanchez-Niño MD, Ramos AM, et al. NF-kappaB in renal inflammation. J Am Soc Nephrol. 2010;21(8):1254–1262. doi:10.1681/ASN.2010020218
   PubMed Web of Science ®Google Scholar
• Percy CJ, Brown L, Power DA, Johnson DW, Gobe GC. Obesity and hypertension have differing oxidant handling molecular pathways in age-related chronic kidney disease. Mech Ageing Dev. 2009;130(3):129–138. doi:10.1016/j.mad.2008.10.003
   PubMed Web of Science ®Google Scholar
• Guijarro C, Egido J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int. 2001;59(2):415–424. doi:10.1046/j.1523-1755.2001.059002415.x
   PubMed Web of Science ®Google Scholar
• Sheedfar F, Di Biase S, Koonen D, Vinciguerra M. Liver diseases and aging: friends or foes? Aging Cell. 2013;12(6):950–954. doi:10.1111/acel.12128
   PubMed Web of Science ®Google Scholar
• Byrne CD. Dorothy Hodgkin lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. Diabet Med. 2012;29(9):1098–1107. doi:10.1111/j.1464-5491.2012.03732.x
   PubMed Web of Science ®Google Scholar
• Byrne CD. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. Proc Nutr Soc. 2013;72(4):412–419. doi:10.1017/S0029665113001249
   PubMed Web of Science ®Google Scholar
• Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;300(5):G697–702. doi:10.1152/ajpgi.00426.2010
   PubMed Web of Science ®Google Scholar
• Altunkaynak B, Özbek E. Histological assessment of obesity induced NAFLD in female obese rats. Paper presented at: 17th National Electron Microscopy Congress; 2005.
   Google Scholar
• Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003;37(5):1202–1219. doi:10.1053/jhep.2003.50193
   Google Scholar
• Luo F, Ishigami M, Achiwa K, et al. Raloxifene ameliorates liver fibrosis of nonalcoholic steatohepatitis induced by choline-deficient high-fat diet in ovariectomized mice. Dig Dis Sci. 2015;60(9):2730–2739. doi:10.1007/s10620-015-3660-6
   PubMed Web of Science ®Google Scholar
• Maffei L, Murata Y, Rochira V, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab. 2004;89(1):61–70. doi:10.1210/jc.2003-030313
   PubMed Web of Science ®Google Scholar
• Nemoto Y, Toda K, Ono M, et al. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest. 2000;105(12):1819–1825. doi:10.1172/JCI9575
   PubMed Web of Science ®Google Scholar
• Ribas V, Nguyen MT, Henstridge DC, et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab. 2010;298(2):E304–319. doi:10.1152/ajpendo.00504.2009
   PubMed Web of Science ®Google Scholar
• Bryzgalova G, Gao H, Ahren B, et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia. 2006;49(3):588–597. doi:10.1007/s00125-005-0105-3
   PubMed Web of Science ®Google Scholar
• Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000;97(23):12735–12740. doi:10.1073/pnas.97.23.12735
   PubMed Web of Science ®Google Scholar
• Deshaies Y, Dagnault A, Lalonde J, Richard D. Interaction of corticosterone and gonadal steroids on lipid deposition in the female rat. Am J Physiol. 1997;273(2 Pt 1):E355–362. doi:10.1152/ajpendo.1997.273.2.E355
   PubMedGoogle Scholar
• Picard F, Deshaies Y, Lalonde J, et al. Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats. Int J Obes Relat Metab Disord. 2000;24(7):830–840. doi:10.1038/sj.ijo.0801240
   PubMed Web of Science ®Google Scholar
• Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond). 2011;120(9):357–375. doi:10.1042/CS20100476
   PubMed Web of Science ®Google Scholar
• Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005;46(3):454–462. doi:10.1161/01.HYP.0000177474.06749.98
   PubMed Web of Science ®Google Scholar
• Barakat R, Oakley O, Kim H, Jin J, Ko CJ. Extra-gonadal sites of estrogen biosynthesis and function. BMB Rep. 2016;49(9):488–496. doi:10.5483/BMBRep.2016.49.9.141
   PubMed Web of Science ®Google Scholar
• Meng X, Dai X, Liao TD, et al. Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice. Life Sci. 2011;88(3–4):178–186. doi:10.1016/j.lfs.2010.11.008
   PubMed Web of Science ®Google Scholar